CD274 and cancer: Given that PD-L1 is frequently over-expressed in various cancers (Dong et al., 2002; Audrito et al., 2017; Bertucci and Goncalves, 2017), finding small molecular compounds that suppress PD-L1 expression might be an efficient strategy.